FULCRUM NEUROSCIENCE, INC

From the company

Fulcrum Neuroscience develops a proprietary mathematical model of brain metabolism and a homeostasis-first, mechanism-first modeling platform for AI drug discovery in neurodegeneration. The platform generates virtual populations of tens of millions of discrete trajectories and has produced a unified hypothesis of Alzheimer's Disease implicating cholesterol debris processing upstream of amyloid and tau. The company is developing proprietary Alzheimer's therapeutics and biomarkers and assists partners by modeling disease progression, therapeutic effects, b